Advertisement

Topics

Search Results for "Par Excel Pharmaceutical San Diego Sorrento Valley"

15:24 EST 10th December 2016 | BioPortfolio

Matching Channels

Rift Valley fever

California

In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over ...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Baxter

Baxter is one of the 30 largest pharmaceutical companies in the world with annual sales of $7.8 billion. With a foot in both the pharmaceutical industry and medical devices, Baxter Healthcare has ...

Germany

Germany is one the top 5 countries in Europe for the biotechnology industry. The €2 billion Innovative Medicines stimulus from the EU has helped, but that is spread over the continent. Over a d...

Matching News

#jobs #lifescience Accounts Payable Specialist Job in Sorrento Valley

// CA-San Diego, Accounts Payable Job in La Jolla I am partnering with an exciting biotech company in Torrey Pines the needs some additional hands for a temporary Accounts Payable need. The company va...

Sorrento to Form CAR/Killer Cell JV with Korea's CHA Biotech

San Diego's Sorrento Therapeutics has signed a binding term sheet to form a joint venture with CHA Biotech of South Korea. The JV will combine five of Sorrento's Chimeric Antigen Receptors for oncolog...

French Pharma licenses California PD-1 Cancer Antibody for €710M

San Diego’s Sorrento Therapeutics has bagged a quarter-billion euro deal with Servier. The French Pharma giant will develop Sorrento’s PD-1 targeting platform – a key checkpoint in...

Servier gets rights to Sorrento's preclinical PD-1 mAb

Sorrento Therapeutics Inc. (NASDAQ:SRNE) granted Servier (Neuilly-sur-Seine, France) an exclusive, worldwide license to STI-A1110, a preclinical mAb against PD-1. Servier expects to study STI-A1110 in...

Sorrento, Korea's Cha setting up global JV

Sorrento Therapeutics Inc. (NASDAQ:SRNE) and Cha Bio&Diostech Co. Ltd. (KOSDAQ:085660) are forming a JV to develop and commercialize chimeric antigen receptor (CAR)-modified cell therapies globally, e...

Sorrento lures former Celgene exec as CMO

US clinical-stage biotech firm Sorrento Therapeutics has appointed Jerome Zeldis, former chief medical…

Sorrento sets up JV with Korea’s CHA Biotech

US clinical-stage biopharma firm Sorrento Therapeutics has entered into a binding term sheet to create…

Sorrento share price dips on latest acquisition

US clinical-stage biopharma firm Sorrento Therapeutics is buying up again, this time to acquire a UK…

Matching PubMed Articles

Nearly perfect valley filter in silicene.

We demonstrate theoretically how a perfect valley filter can be obtained in silicene under the effects of a ferromagnetic stripe and an electric field perpendicular to silicene. A ferromagnetic stripe...

Electrical control of the valley Hall effect in bilayer MoS2 transistors.

The valley degree of freedom of electrons in solids has been proposed as a new type of information carrier, beyond the electron charge and spin. The potential of two-dimensional semiconductor transiti...

Valley polarization by spin injection in a light-emitting van der Waals heterojunction.

The band structure of transition metal dichalcogenides (TMDCs) with valence band edges at different locations in the momentum space could be harnessed to build devices that operate relying on the vall...

Kantis: A new Australopithecus site on the shoulders of the Rift Valley near Nairobi, Kenya.

Most Plio-Pleistocene sites in the Gregory Rift Valley that have yielded abundant fossil hominins lie on the Rift Valley floor. Here we report a new Pliocene site, Kantis, on the shoulder of the Grego...

A Route to Permanent Valley Polarization in Monolayer MoS2.

Realization of permanent valley polarization in Cr-doped monolayer MoS2 is found to be unfeasible because of extended moment formation. Introduction of an additional hole is suggested as a viable solu...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement